Alejandro Bravo-Patiño

Alejandro Bravo-Patiño

Auto-generated profile, based on publicly available information

Alejandro Bravo-Patiño

Facultad de Medicina Veterinaria y Zootecnia, Posta Veterinaria y Zootecnia de la Universidad Michoacana de San Nicolás de Hidalgo, Universidad Michoacana de San Nicolás de Hidalgo, Edificio G. Km. 9.5 S/N, Carretera Morelia-Zinapécuaro, C.P. 58893, La Palma, Tarímbaro, Michoacán, Mexico

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 June 2012 in Journal of Inflammation
Verified
Journal Article
Open access
PDF file
RCRicarda Cortés-Vieyra
Ricarda Cortés-Vieyra
ABAlejandro Bravo-Patiño
Alejandro Bravo-Patiño
JVJuan J Valdez-Alarcón
Juan J Valdez-Alarcón
MJMarcos Cajero Juárez
Marcos Cajero Juárez
BFB Brett Finlay
B Brett Finlay
VBVictor Manuel Baizabal-Aguirre
Victor Manuel Baizabal-Aguirre
Glycogen synthase kinase 3β (GSK3β) plays a fundamental role during the inflammatory response induced by bacteria. Depending on the pathogen and its virulence factors, the type of cell and probably the context in which the interaction between host cells and bacteria takes place, GSK3β may promote or inhibit inflammation. The goal of this review is to discuss recent findings on the role of the inhibition or activation of GSK3β and its modulation of the inflammatory signaling in monocytes/macrophages and epithelial cells at the transcriptional level, mainly through the regulation of nuclear factor-kappaB (NF-κB) activity. Also included is a brief overview on the importance of GSK3 in non-inflammatory processes during bacterial infection.

1 March 2016 in Cell Division
Verified
Journal Article
Open access
PDF file
HCHumberto Contreras-Cornejo
Humberto Contreras-Cornejo
GSGermán Saucedo-Correa
Germán Saucedo-Correa
JOJavier Oviedo-Boyso
Javier Oviedo-Boyso
JVJuan José Valdez-Alarcón
Juan José Valdez-Alarcón
VBVictor Manuel Baizabal-Aguirre
Victor Manuel Baizabal-Aguirre
ABAlejandro Bravo-Patiño
Alejandro Bravo-Patiño
The Notch signaling pathway is a reiteratively used cell to cell communication pathway that triggers pleiotropic effects. The correct regulation of the pathway permits the efficient regulation of genes involved in cell fate decision throughout development. This activity relies notably on the CSL proteins, (an acronym for CBF-1/RBPJ-κ in Homo sapiens/Mus musculus respectively, Suppressor of Hairless in Drosophila melanogaster, Lag-1 in Caenorhabditis elegans) which is the unique transcription factor and DNA binding protein involved in this pathway. The CSL proteins have the capacity to recruit activation or repression complexes according to the cellular context. The aim of this review is to describe the different co-repressor proteins that interact directly with CSL proteins to form repression complexes thereby regulating the Notch signaling pathway in animal cells to give insights into the paralogous evolution of these co-repressors in higher eumetazoans and their subsequent effects at developmental processes.

5 October 2012 in World Journal of Microbiology and Biotechnology
Verified
Journal Article
Closed access
PDF file
GVGabriela Villegas-Rivera
Gabriela Villegas-Rivera
YVYevani Vargas-Cabrera
Yevani Vargas-Cabrera
NGNapoleón González-Silva
Napoleón González-Silva
FAFlorentino Aguilera-García
Florentino Aguilera-García
EGErnestina Gutiérrez-Vázquez
Ernestina Gutiérrez-Vázquez
JVJuan José Valdez-Alarcón
Juan José Valdez-Alarcón

11 May 2017 in Journal of Economic Entomology
Verified
Journal Article
Closed access
PDF file
NANORMA ZAMORA AVILES
NORMA ZAMORA AVILES
RMRosa Murillo
Rosa Murillo
RLRodrigo Lasa
Rodrigo Lasa
SPSamuel Pineda-Guillermo
Samuel Pineda-Guillermo
JRJOSÉ ISAAC FIGUEROA DE LA ROSA
JOSÉ ISAAC FIGUEROA DE LA ROSA
AMAna Mabel Martínez-Castillo
Ana Mabel Martínez-Castillo
This study describes four multiple nucleocapsid nucleopolyhedrovirus isolates recovered from infected larvae of beet armyworm, Spodoptera exigua (Hübner) (Lepidoptera: Noctuidae), on crops in two different geographical regions of Mexico. Molecular and biological characterization was compared with characterized S. exigua multiple nucleopolyhedrovirus (SeMNPV) isolates from the United States (SeUS1 and SeUS2) and Spain (SeSP2). Restriction endonuclease analysis of viral DNA confirmed that all Mexican isolates were SeMNPV isolates, but molecular differences between the Mexican and the reference isolates were detected using PCR combined with restriction fragment length polymorphism (RFLP). Amplification of the variable region V01 combined with RFLP distinguished the two Mexican isolates, SeSLP6 and SeSIN6. BglII digestions showed that the majority of the isolates contained submolar bands, indicating the presence of genetic heterogeneity. Amplification of the variable regions V04 and V05 distinguished between American and the Spanish isolates. Biological characterization was performed against two laboratory colonies of S. exigua, one from Mexico, and another from Switzerland. Insects from the Mexican colony were less susceptible to infection than insects from Se-Swiss colony. In the Se-Mex colony, SeSP2 was the most pathogenic isolate followed by SeSIN6, although their virulence was similar to most of the isolates tested. In Se-Swiss colony, similar LD50 values were observed for the five isolates, although the virulence was higher for the SeSLP6 isolate, which also had the highest OB (occlusion body) yield. We conclude that the Mexican isolates SeSIN6 and SeSLP6 possess insecticidal traits of value for the development of biopesticides for the control of populations of S. exigua.

2 November 2017 in Biocontrol Science and Technology
Verified
Journal Article
Closed access
NANORMA ZAMORA AVILES
NORMA ZAMORA AVILES
AMAna Mabel Martínez-Castillo
Ana Mabel Martínez-Castillo
SPSamuel Pineda-Guillermo
Samuel Pineda-Guillermo
ABA. Bravo-Patiño
A. Bravo-Patiño
JRJOSÉ ISAAC FIGUEROA DE LA ROSA
JOSÉ ISAAC FIGUEROA DE LA ROSA
RLRodrigo Lasa
Rodrigo Lasa
The incorporation of baculovirus into semi-synthetic diets has been used for the inoculation of large batches of insect larvae reared under gregarious conditions. The preparation of most artificial diets involves heating to dissolve the agar gelling agent followed by cooling to ∼55–60°C whereupon virus occlusion bodies (OBs) are incorporated into the diet. To avoid exposure of thermolabile OBs to high temperatures, a cool-textured diet using soy fiber was evaluated as a simple method to inoculate batches of larvae with the baculovirus OBs. Spodoptera exigua larvae that fed on a diet with 120, 140 or 160 g/l of soy fiber, as a substitute for agar, had a similar weight gain over a 24 h period than larvae that consumed a standard agar diet. The larval weight gain with cool-textured diets with 140 g/l of soy fiber was not improved by the addition of chlorophyll, green food dye colour, or by the removal of ascorbic acid, sodium benzoate and potassium sorbate. Preliminary tests performed to determine the optimal OBs concentration needed for the inoculation of groups of four instar larvae in agar and soy fiber diets revealed no virus inactivation in heated diets with a similar optimal concentration of 36 OBs mg−1 for both diets. Moreover, no significant differences were observed in OB production when each type of diet was used to inoculate groups of 250 larvae reared gregariously in plastic containers. Cool-textured diets could be of interest for the production of baculoviruses that require a diet that can be prepared quickly and easily.

2 July 2024 in Microbiology Spectrum
Verified
Journal Article
Open access
RCRicarda Cortés-Vieyra
Ricarda Cortés-Vieyra
SGSergio Gutiérrez-Castellanos
Sergio Gutiérrez-Castellanos
AGAnel Gómez-García
Anel Gómez-García
ABAlejandro Bravo-Patiño
Alejandro Bravo-Patiño
FCFernando Calderón-Rico
Fernando Calderón-Rico
Rosa Elvira Nuñez-AnitaRosa Elvira Nuñez-Anita
Rosa Elvira Nuñez-Anita
This study aimed to investigate the immunomodulatory behavior of soluble immune checkpoints (sICPs) and other biomarkers in the pathophysiology of SARS-CoV-2 infection. The study included 59 adult participants, 43 of whom tested positive for SARS-CoV-2. Patients were divided into three cohorts: those with moderate disease ( n = 16), recovered patients with severe disease ( n = 13), and deceased patients with severe disease ( n = 16). In addition, 16 participants were pre-pandemic subjects negative for SARS-CoV-2. The relative activity of neutralizing antibodies (rNAbs) against SARS-CoV-2 and the values of 14 sICPs in peripheral blood were compared between the four groups. Because the increase of markers values of inflammation [NLR > 12; CRP > 150 mg/L] and venous thromboembolism [D-dimer > 0.5 mg/L] has been associated with mortality from COVID-19, the total and differential leukocyte counts, the NLR, and CRP and D-dimer values were obtained in patients with severe disease. No differences in rNAbs were observed between the cohorts. Only the levels of five sICPs, sCD27, sHVEM sTIM-3, sPD-1, and sPDL-1, were significantly higher in patients with severe rather than moderate disease. The sPDL-2 level and NLR were higher in deceased patients than in recovered patients. However, there was no difference in CRP and D-dimer values between the two groups. Of the five soluble biomarkers compared among patients with severe disease, only sPDL-2 was higher in deceased patients than in recovered patients. This suggests that immuno-inhibitory sICPs might be used as indicators for severe COVID-19, with sPDL-2 used to assess individual risk for fatality. IMPORTANCE: COVID-19, the disease caused by a SARS-CoV-2 infection, generates a broad spectrum of clinical symptoms, progressing to multiorgan failure in the most severe cases. As activation of the immune system is pivotal to eradicating the virus, future research should focus on identifying reliable biomarkers to efficiently predict the outcome in severe COVID-19 cases. Soluble immune checkpoints represent the function of the immune system and are easily determined in peripheral blood. This research could lead to implementing more effective severity biomarkers for COVID-19, which could increase patients’ survival rate and quality of life.